Neurocrine Biosciences | 营业利润

Operating Profit 更改 日
AbbVie USD 2.96B 233M 2024-03
Acadia Pharmaceuticals USD 15.21M 19.73M 2024-03
Agios Pharmaceuticals USD -92072000 14.2M 2024-03
ALKERMES USD 43.31M 11.32M 2024-03
Alnylam Pharmaceuticals USD -43435000 72.97M 2024-03
Amgen USD 991M 280M 2024-03
Biogen USD 570M 211.1M 2024-03
BioMarin Pharmaceutical USD 78.46M 64.24M 2024-03
Cytokinetics USD -126235000 1.18M 2024-03
Dynavax Technologies USD -17769000 9.28M 2024-03
Exelixis USD 62.3M 79.88M 2024-03
Gilead Sciences USD -191000000 1.8B 2024-03
Halozyme Therapeutics USD 95.54M 5.49M 2024-03
Incyte USD 91.35M 95.92M 2024-03
Intra Cellular Therapies USD -20952000 13.14M 2024-03
Ionis Pharmaceuticals USD -149513000 170.19M 2024-03
Neurocrine Biosciences USD 105.3M 35.9M 2024-03
Pfizer USD 4.2B 10.75B 2024-03
Prothena USD -81528000 3.01M 2024-03
Regeneron Pharmaceuticals USD 758.5M 214.4M 2024-03
Repligen USD 2.73M 16.29M 2024-03
Sarepta Therapeutics USD 34.9M 83.25M 2024-03
Teva Pharmaceutical Industries USD 642M 113M 2024-03
Ultragenyx Pharmaceutical USD -165347000 43.3M 2024-03
Vertex Pharmaceuticals USD 1.22B 178.1M 2024-03



Neurocrine Biosciences 营业利润 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.